🧠🔬McDonald Criteria2024

🧠🔬 McDonald Criteria 2024 – High-Yield Summary

Definition:
MS diagnosis requires Dissemination in Space (DIS) 🌐) and Dissemination in Time (DIT ⏳), plus exclusion of alternative diagnoses.

🔹 Key Updates in 2024 Revision

1️⃣ Dissemination in Space (DIS) 🌐

• Lesions must involve ≥1 of 5 CNS regions:
  • 🧩 Periventricular
  • 🧠 Juxtacortical / Cortical
  • 🏰 Infratentorial
  • 🦴 Spinal cord
  • 👁️ Optic nerve ✅ (new inclusion)

2️⃣ Dissemination in Time (DIT) ⏳

• Not strictly required in some cases
• Single clinical event or radiologically isolated cases may suffice with supporting evidence

3️⃣ New Biomarkers 🧬

• Kappa Free-Light Chain (kFLC) index in CSF ✅ (alternative to oligoclonal bands)
• Detects intrathecal antibody production 🧪

4️⃣ Advanced MRI Features 🖥️🧲

• Central Vein Sign (CVS) 💉
• Paramagnetic Rim Lesions (PRL) 🔵
• Helps differentiate MS lesions from vascular/migraine lesions

5️⃣ Flexibility for Special Populations 👶🧓

• Radiologically Isolated Syndrome (RIS) 📸: MRI lesions + biomarkers may allow early diagnosis
• Pediatric-onset MS 👦👧: Consider MOG-antibody testing in atypical events
• Older adults ≥50 🧓: Require robust evidence (spinal lesions, CSF/kFLC+, or multiple CVS+ lesions)

⚡ Strengths / Advantages ✅

• Earlier diagnosis ⏱️ → prompt treatment, relapse prevention
• More sensitive & flexible 🔬 — includes optic nerve involvement, isolated MRI lesions
• New biomarkers 🧪 improve specificity → reduce misdiagnosis

⚠️ Limitations / Cautions ⚠️

• Older adults / vascular comorbidities → require stronger evidence
• CVS/PRL need high-quality MRI sequences 🖥️ — may not be available everywhere
• Diagnosis = one of exclusion ❌ (rule out infection 🦠, vascular 🫀, metabolic ⚗️, MOG-associated disorders)

📝 Practical Tips for Resource-Limited Settings 💡

• Use kFLC index 🧬 if OCB testing unavailable
• Optic MRI 👁️, VEP ⚡, OCT 🔬 for optic neuritis
• Interpret advanced MRI signs carefully if specialized sequences not available